Stroke Trial, Recruiting (NCT06887855)

Stroke Trial, Recruiting NCT06887855 Sponsor: Hamad Medical Corporation Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT06887855 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People between 18 and 75 years old
People who have been diagnosed with a swallowing problem between one day and six months after having a stroke
People who are able to attend 10 therapy sessions
People who have not received any swallowing treatment before joining this study

Who may not be able to join:

People who have had a stroke and also have severe problems with thinking, memory, or understanding
People whose swallowing problems are caused by something other than a stroke
People who need a type of swallowing therapy other than the two specific methods used in this trial (called Expiratory Muscle Strength Training and Chin Tuck Against Resistance)
People who have a skin condition on the front of the neck or under the chin
People who have other medical conditions that may affect their ability to take part (confirm with trial site)
People who have a defibrillator or who use certain medical electrical devices, such as a pacemaker

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ibrahim Mohammad Alayaseh, M.Sc. _ SLP, Hamad Medical Corporation

Phone: + 974 66888533

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06887855

Sponsor: Hamad Medical Corporation

Phase: Not Applicable

Status: Recruiting

Condition: Stroke

Trial contact: + 974 66888533

More information: https://clinicaltrials.gov/study/NCT06887855

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People between 18 and 75 years old
People who have been diagnosed with a swallowing problem between one day and six months after having a stroke
People who are able to attend 10 therapy sessions
People who have not received any swallowing treatment before joining this study

Who may not be able to join:

People who have had a stroke and also have severe problems with thinking, memory, or understanding
People whose swallowing problems are caused by something other than a stroke
People who need a type of swallowing therapy other than the two specific methods used in this trial (called Expiratory Muscle Strength Training and Chin Tuck Against Resistance)
People who have a skin condition on the front of the neck or under the chin
People who have other medical conditions that may affect their ability to take part (confirm with trial site)
People who have a defibrillator or who use certain medical electrical devices, such as a pacemaker

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Hamad Medical Corporation

Registry

ClinicalTrials.gov

Start date

1 November 2024

Est. completion

30 August 2025

Where this trial is recruiting

Qatar

Primary endpoints

Penetration-Aspiration Scale (PAS) score; Dysphagia Handicap Index; surface Electromyography (sEMG)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov